Abstract
BackgroundReactivation of tumor infiltrating T lymphocytes (TILs) with immune checkpoint inhibitors or co-stimulators has proven to be an effective anti-cancer strategy for a broad range of malignancies. However, epithelial ovarian...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have